Skip to main navigation Skip to search Skip to main content

Phase I and pharmacologic study of liposomal lurtotecan (NX 211): Urinary Excretion predicts hematologic toxicity

  • D Kehrer
  • , AM Bos
  • , Jaap Verweij
  • , HJ Groen
  • , Walter Loos
  • , A Sparreboom
  • , Maja de Jonge
  • , M Hamilton
  • , T Cameron
  • , EGE de Vries

Research output: Contribution to journalArticleAcademicpeer-review

46 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1222-1231
Number of pages10
JournalJournal of Clinical Oncology
Volume20
Issue number5
DOIs
Publication statusPublished - 2002

Research programs

  • EMC MM-03-86-08

Cite this